Monthly Prescribing Reference

Botox Approval Expanded to Include 8 New Muscles for Upper Limb Spasticity

The indication for adult upper limb spasticity treatment now includes elbow and forearm muscles, intrinsic hand muscles, and thumb muscles. The Food and Drug Administration (FDA) has expanded the ...
Nasdaq

FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity

-- BOTOX® has demonstrated efficacy and has an established safety profile with over 10 years of clinical use in adult upper limb spasticity NORTH CHICAGO, Ill., July 29, 2021 /PRNewswire/ -- Allergan, ...
FiercePharma

Actavis Announces FDA Approval of Expanded Label for BOTOX(R) (OnabotulinumtoxinA) for the Treatment of Upper Limb Spasticity in Adults

Label updates include addition of two thumb flexor muscles and increased maximum cumulative dose DUBLIN, April 20, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT), which recently completed the ...
BMJ

608 EP054 – Unlocking enhanced exercise benefits: blood flow restriction for safer and more effective workouts in individuals with spinal cord injuries

Background People with incomplete spinal cord injury (SCI) commonly experience limb muscle atrophy and dysfunction, which reduce their ability to handle their activities of daily living and ...
Science Daily

Enzyme hyaluronidase shows promise as treatment for muscle stiffness caused by brain injury

A naturally occurring enzyme called hyaluronidase may be an effective alternative treatment for spasticity, or muscle stiffness, a disabling condition in people who have had a stroke or other brain ...